Emerging therapeutics in the management of connective tissue disease. Part II: Dermatomyositis and scleroderma
Vijay Kodumudi(UConn Health), Jun Lu(UConn Health), Jónas A. Aðalsteinsson(Mount Sinai Hospital), Neda Shahriari(Brigham and Women's Hospital), Lorin A. Bibb(University of Connecticut), Sueheidi Santiago(UConn Health), Jane M. Grant‐Kels(University of Connecticut), Lauren Skudalski(Geisinger Commonwealth School of Medicine)
Cited by 6
Related Papers
Guidelines of care for the management of primary cutaneous melanoma
|Journal of the American Academy of Dermatology|2018|707
The Diagnostic Performance of Expert Dermoscopists vs a Computer-Vision System on Small-Diameter Melanomas
|Archives of Dermatology|2008|88
Reflectance confocal microscopy
|Journal of the American Academy of Dermatology|2020|76
Assessment of Clinical Response to Anifrolumab in Patients With Refractory Discoid Lupus Erythematosus
|JAMA Dermatology|2023|51
Reflectance confocal microscopy
|Journal of the American Academy of Dermatology|2020|47